Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

A Mortality Analysis of Letermovir Prophylaxis for Cytomegalovirus (CMV) in CMV-Seropositive Recipients of Allogeneic Hematopoietic-Cell Transplantation.

Ljungman P, Schmitt M, Marty FM, Maertens J, Chemaly RF, Kartsonis NA, Butterton JR, Wan H, Teal VL, Sarratt K, Murata Y, Leavitt RY, Badshah C.

Clin Infect Dis. 2019 Jun 8. pii: ciz490. doi: 10.1093/cid/ciz490. [Epub ahead of print]

PMID:
31179485
2.

Letermovir Prophylaxis for Cytomegalovirus.

Marty FM, Maertens J, Badshah C.

N Engl J Med. 2018 Mar 8;378(10):965. doi: 10.1056/NEJMc1800572. No abstract available.

PMID:
29514025
3.

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation.

Marty FM, Ljungman P, Chemaly RF, Maertens J, Dadwal SS, Duarte RF, Haider S, Ullmann AJ, Katayama Y, Brown J, Mullane KM, Boeckh M, Blumberg EA, Einsele H, Snydman DR, Kanda Y, DiNubile MJ, Teal VL, Wan H, Murata Y, Kartsonis NA, Leavitt RY, Badshah C.

N Engl J Med. 2017 Dec 21;377(25):2433-2444. doi: 10.1056/NEJMoa1706640. Epub 2017 Dec 6.

4.

Efficacy and safety of 12 weeks of elbasvir ± grazoprevir ± ribavirin in participants with hepatitis C virus genotype 2, 4, 5 or 6 infection: The C-SCAPE study.

Brown A, Hézode C, Zuckerman E, Foster GR, Zekry A, Roberts SK, Lahser F, Durkan C, Badshah C, Zhang B, Robertson M, Wahl J, Barr E, Haber B; C-SCAPE Study Investigators.

J Viral Hepat. 2018 May;25(5):457-464. doi: 10.1111/jvh.12801. Epub 2018 Mar 14.

PMID:
29152828
5.

Seizure with acute pulmonary infiltrates.

Nog R, Dumor K, Badshah C.

Am J Med. 2011 Nov;124(11):e1-2. doi: 10.1016/j.amjmed.2011.03.023. Epub 2011 Jun 30. No abstract available.

PMID:
21722863
7.

The leader polypeptide of Theiler's virus is essential for neurovirulence but not for virus growth in BHK cells.

Calenoff MA, Badshah CS, Dal Canto MC, Lipton HL, Rundell MK.

J Virol. 1995 Sep;69(9):5544-9.

Supplemental Content

Loading ...
Support Center